contextflow develops deep-learning software that helps radiologists analyze chest CT scans for suspected lung cancer, interstitial lung disease and COPD. Its ADVANCE Chest CT platform detects and measures pulmonary nodules, tracks them across follow-up scans, quantifies lung tissue abnormalities, assesses incidental coronary artery calcium and retrieves comparable imaging cases within radiologists’ existing viewers. Its broader solution suite integrates RevealAI-Lung nodule risk assessment and CINA-iPE pulmonary embolism detection. Founded as a Medical University of Vienna spinout, contextflow GmbH became part of 4DMedical’s European expansion in 2026; 4DMedical describes the acquisition as completed in its August 3, 2026 publication.
